Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/07/2877279/0/en/Jasper-Therapeutics-to-Present-at-Upcoming-Investor-Conferences-in-May.html
https://www.globenewswire.com/news-release/2024/04/02/2856491/0/en/Jasper-Therapeutics-to-Present-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/21/2850645/0/en/Jasper-Therapeutics-to-Participate-in-the-H-C-Wainwright-2nd-Annual-Autoimmune-Inflammatory-Disease-Virtual-Conference.html
https://www.globenewswire.com/news-release/2024/03/19/2848524/0/en/Jasper-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2a-SPOTLIGHT-Clinical-Study-of-Briquilimab-in-Chronic-Inducible-Urticaria.html
https://www.globenewswire.com//news-release/2024/03/15/2847004/0/en/New-Positive-Data-Presented-on-Briquilimab-Conditioning-in-Patients-with-Fanconi-Anemia.html
https://www.globenewswire.com//news-release/2024/03/04/2839472/0/en/Jasper-Therapeutics-Reports-Fiscal-2023-Financial-Results-and-Recent-Corporate-Developments.html
https://www.globenewswire.com//news-release/2024/02/26/2835529/0/en/Jasper-Therapeutics-to-Present-at-the-43rd-Annual-TD-Cowen-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/23/2834438/0/en/Jasper-Therapeutics-Presents-Data-from-Preclinical-Briquilimab-Studies-at-the-American-Academy-of-Allergy-Asthma-and-Immunology-AAAAI-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/07/2825163/0/en/Jasper-Therapeutics-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824392/0/en/Jasper-Therapeutics-Announces-Pricing-of-50-Million-Underwritten-Offering-of-Common-Stock.html